Hanna Kleczkowska
Director
pharmaceutical sciences
Amal Therapeutics
Netherlands
Biography
Hanna Kleczkowska is the Principal Investment Advisor at Helsinn International Services (HIS), an advisory body to the Helsinn Investment Fund. Before joining HIS, Hanna worked for Helsinn Healthcare in the Business Development function, leading a team focusing on new product evaluations for in-licensing or acquisition. Prior to Helsinn, Hanna held senior management positions at Bank Julius Baer and UBS, where she had been involved in private and public equity transactions. Hanna started her career at the University of Zurich where she did independent research on the molecular mechanisms of cancer. Later on, at the Ludwig Institute for Cancer Research, she coordinated a cancer biomarker database project. Hanna holds a Ph.D. in Molecular Biology from University of Warsaw
Research Interest
